Effect of RANKL Inhibition by Denosumab on Serum Cholesterol in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Grazette, L. [1 ]
Daizadeh, N. [1 ]
Wang, A. [1 ]
Haller, C. [1 ]
Daniels, A. [1 ]
Siddhanti, S. [1 ]
Bolognese, M. A. [2 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Bethesda Hlth Rsch Cntr, Bethesda, MD USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2010年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E211 / E211
页数：1
相关论文
共 50 条
  • [21] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
    Scott, Lesley J.
    DRUGS & AGING, 2014, 31 (07) : 555 - 576
  • [22] Effects of alendronate treatment on serum levels of osteoprotegerin and total RANKL in women with postmenopausal osteoporosis
    Reyes-García, R
    Fernández-García, D
    Mezquita-Raya, P
    De la Higuera, M
    Alonso, G
    Ruiz-Requena, ME
    Escobar-Jiménez, F
    Muñoz-Torres, M
    BONE, 2005, 36 : S410 - S411
  • [23] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
    Lesley J. Scott
    Drugs & Aging, 2014, 31 : 555 - 576
  • [24] The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Savvidis, Matthaios
    Mantzoros, Christos S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (09) : 1306 - 1314
  • [25] HIGH LEVEL OF ENGAGEMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE TREATMENT WITH DENOSUMAB
    Solakov, P.
    Kuzmanova, S.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S239 - S239
  • [26] Spotlight on Denosumab in Postmenopausal Osteoporosis
    Moen, Marit D.
    Keam, Susan J.
    BIODRUGS, 2011, 25 (04) : 261 - 264
  • [27] Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis EDITORIAL COMMENT
    Cummings, Steven R.
    Martin, Javier San
    McClung, Michael R.
    Siris, Ethel S.
    Eastell, Richard
    Reid, Ian R.
    Delmas, Pierre
    Zoog, Holly B.
    Austin, Matt
    Wang, Andrea
    Kutilek, Stepan
    Adami, Silvano
    Zanchetta, Jose
    Libanati, Cesar
    Siddhanti, Suresh
    Christiansen, Claus
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (12) : 805 - 807
  • [28] Denosumab for the Management of Postmenopausal Osteoporosis
    Singer, Andrea
    Grauer, Andreas
    POSTGRADUATE MEDICINE, 2010, 122 (06) : 176 - 187
  • [29] Denosumab for the treatment of postmenopausal osteoporosis
    Lewiecki, E. Michael
    WOMENS HEALTH, 2009, 5 (01) : 15 - 22
  • [30] Denosumab: A Review in Postmenopausal Osteoporosis
    Emma D. Deeks
    Drugs & Aging, 2018, 35 : 163 - 173
12345